| Management target | Revenue 9.0% FY27 |
|---|
| Revenue growth | Revenue fell 12.56% YoY due to delayed monsoons affecting herbicide demand. |
|---|---|
| Margins | EBITDA and PAT under pressure from weak demand and competitive pricing. |
| Demand visibility | Low for Q2; heavily dependent on late-season rainfall and reservoir levels. |
| Management confidence | Balanced but cautious; admitted significant Q1 underperformance and cyclical challenges. |
Growth
Growth is poor; revenue fell to ₹461.93 Cr. Performance is primarily volume-led but hit by cyclical headwinds.
Outlook
Guided single-digit growth for FY27. New ₹200 Cr Nagpur formulation plant expected operational by April 2028.
Risks
Subdued monsoon impact on Q2 visibility; high raw material costs and stiff pricing competition in domestic markets.
Last quarter's promises, checked
Delivered
- Guided low double-digit revenue growth → delivered 9.0% growth (= MISS)
- Guided 25% higher buyback price vs market → delivered ₹1,400 buyback (= BEAT)
Partly delivered
- Guided EBITDA margin decline of 100 bps → delivered expansion in Q4 due to GST refund (= BEAT)
Missed
- Guided 25-26% revenue from 9-3 products → delivered 26% (= BEAT)
- Guided Dahej revenue ₹65 Cr for FY26 → delivered ₹50 Cr (= MISS)
Earnings Call Transcript filed with BSE, NSE: DHANUKA. Summary written with AI assistance from the document.
Dhanuka Agritech Ltd: key numbers
- Share price
- ₹964.35
- Market cap
- ₹4,347 Cr
- Revenue (annual)
- ₹2,020 Cr
- Net profit (annual)
- ₹287.2 Cr
- Promoter holding
- 69.81%+0.10% QoQ
- FII holding
- 1.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dhanuka Agritech Ltd
All →Dhanuka Agritech Product Launch
Dhanuka Agritech has launched 'POLIN', a new fungicide, in the domestic Indian market. This product features a novel mode of action for enhanced crop protection.
Dhanuka Agritech Credit Rating
CARE Ratings reaffirmed Dhanuka Agritech's bank facilities at 'CARE AA; Stable' and 'CARE A1+'. These ratings assess the company's financial and operational performance.
Dhanuka Agritech Employee Stock Options
Dhanuka Agritech Limited received in-principle approval from NSE and BSE to list up to 50,000 equity shares issued under its ESOP 2026 scheme.
Dhanuka Agritech Investor Presentation: Key Takeaways
Q1FY27 revenue and profitability declined sharply due to delayed monsoon and price competition. Management is pivoting towards new product launches and a ₹200-crore capex for a manufacturing plant in Nagpur.
Dhanuka Agritech Q1 FY27 Results: Net Profit ₹36.3 Cr, Down 34.6% YoY
Dhanuka Agritech Ltd reported revenue from operations of ₹461.9 Cr (-12.6% YoY) and net profit of ₹36.3 Cr (-34.6% YoY) for Q1 FY27.
- Key figure
- Net profit ₹36.3 Cr · -34.6% YoY
Dhanuka Agritech Earnings Call: Key Takeaways
Dhanuka delivered 9% revenue growth in Q4FY26 despite challenging weather. EBITDA rose to ₹124.89cr and PAT reached ₹97.77cr, supported by a significant GST refund and improved product mix.